OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends and Best Practices at DCAT Week
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems.
Albuquerque, NM, February 24, 2011 --(PR.com)-- OSO BioPharmaceuticals Manufacturing, LLC, will sponsor the Biologics Forum taking place March 16 as part of DCAT Week.
OsoBio is a contract manufacturing organization focusing on biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products that require complex handling, including highly potent compounds.
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. Participants will learn about innovations in products, tools and practices, as well as practical applications with case studies.
“Methodologies for qualifying primary container and delivery devices remain somewhat vague, which is why discussing case studies and sharing best practices is useful within the pharmaceutical industry,” said Stuart Rose, president and CEO of OsoBio. “OsoBio is pleased to sponsor an event that advances quality and safety knowledge in our industry, ultimately benefiting the patients we all seek to serve.”
DCAT Week – sponsored annually by the Drug, Chemical and Associated Technologies Association (DCAT) – is considered by many participating industry representatives to be one of the most important meetings of the year.
The Biologics Forum is scheduled to take place Wednesday, March 16, from 1:15 p.m. to 4:30 p.m. in the Empire Room at the Waldorf-Astoria Hotel in New York City. A networking reception will follow.
DCAT invites representatives from non-member companies with interests in biologics to attend this program and networking event for the DCAT member price of $99. For registration information, visit the OsoBio website.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.
Contact: Milton Boyer, VP business development and sales, 706.694.2514
###
OsoBio is a contract manufacturing organization focusing on biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products that require complex handling, including highly potent compounds.
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. Participants will learn about innovations in products, tools and practices, as well as practical applications with case studies.
“Methodologies for qualifying primary container and delivery devices remain somewhat vague, which is why discussing case studies and sharing best practices is useful within the pharmaceutical industry,” said Stuart Rose, president and CEO of OsoBio. “OsoBio is pleased to sponsor an event that advances quality and safety knowledge in our industry, ultimately benefiting the patients we all seek to serve.”
DCAT Week – sponsored annually by the Drug, Chemical and Associated Technologies Association (DCAT) – is considered by many participating industry representatives to be one of the most important meetings of the year.
The Biologics Forum is scheduled to take place Wednesday, March 16, from 1:15 p.m. to 4:30 p.m. in the Empire Room at the Waldorf-Astoria Hotel in New York City. A networking reception will follow.
DCAT invites representatives from non-member companies with interests in biologics to attend this program and networking event for the DCAT member price of $99. For registration information, visit the OsoBio website.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.
Contact: Milton Boyer, VP business development and sales, 706.694.2514
###
Contact
Sinclair & Co.
Karen Stinneford
919-833-9102
http://www.osobio.com/about-events-dcat.html
Karen Stinneford
919-833-9102
http://www.osobio.com/about-events-dcat.html
Contact
Categories